Clinical Trials

Study Title:
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Toros Dincman, at dincmant@musc.edu. Study Coordinator, Bria Sanders, at sandebri@musc.edu. Trial opened at the following institutions: Medical University of South Carolina